Semaglutide
A GLP-1 receptor agonist taken as a once-weekly injection. Doses start low and step up roughly every four weeks, as tolerated.
- Once a week, same day each week
- Gradual titration to limit side effects
- STEP 1 trial: about 15% average loss over 68 weeks1